The stock's fall snapped a two-day winning streak.

Shares of Boston Scientific Corp. BSX advanced 1.48% to $95.52 Tuesday, on what proved to be an all-around grim trading ...

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...

Boston Scientific (NYSE:BSX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ...

Medical device giant Boston Scientific has announced that it has signed a definitive agreement to acquire Israeli medical ...